Artiva Biotherapeutics, Inc. ARTV Payments for finance leases
Payments for finance leases at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s payments for finance leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s payments for finance leases?
- Artiva Biotherapeutics, Inc. (ARTV) reported payments for finance leases of $33K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s payments for finance leases changed year-over-year?
- Artiva Biotherapeutics, Inc.'s payments for finance leases decreased by 0.0% year-over-year, from $33K to $33K.
- What does payments for finance leases mean?
- Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.